Introduction {#hiv12477-sec-0005}
============

Advances in antiretroviral therapy (ART) have resulted in greatly reduced mortality among people living with HIV [1](#hiv12477-bib-0001){ref-type="ref"}, [2](#hiv12477-bib-0002){ref-type="ref"}, such that life expectancy for HIV‐positive individuals with access to treatment now approaches that of the general population [3](#hiv12477-bib-0003){ref-type="ref"}. International [4](#hiv12477-bib-0004){ref-type="ref"}, [5](#hiv12477-bib-0005){ref-type="ref"}, [6](#hiv12477-bib-0006){ref-type="ref"} and UK [7](#hiv12477-bib-0007){ref-type="ref"} guidelines recommend that patients are involved in decision‐making about HIV care and treatment. For this to be achieved, patients require adequate knowledge of their HIV‐related health and treatment goals, and are dependent on health care professionals providing and discussing the relevant information.

Reviewing laboratory markers such as CD4 counts and HIV viral load (VL) in conjunction with a patient is now common practice amongst HIV health care providers. Previous studies have suggested that providing health‐related knowledge to people with HIV infection may improve adherence and treatment outcomes, as well as benefitting the patient−health care provider relationship [8](#hiv12477-bib-0008){ref-type="ref"}, [9](#hiv12477-bib-0009){ref-type="ref"}, [10](#hiv12477-bib-0010){ref-type="ref"}. Furthermore, as increasing evidence shows that a suppressed HIV VL greatly reduces the risk of onward transmission of HIV to sexual partners [11](#hiv12477-bib-0011){ref-type="ref"}, [12](#hiv12477-bib-0012){ref-type="ref"}, [13](#hiv12477-bib-0013){ref-type="ref"}, [14](#hiv12477-bib-0014){ref-type="ref"}, [15](#hiv12477-bib-0015){ref-type="ref"}, [16](#hiv12477-bib-0016){ref-type="ref"}, [17](#hiv12477-bib-0017){ref-type="ref"}, people with HIV infection may use their VL results to make decisions on condomless sex. Therefore, in this context, it is critical that individuals have correct self‐knowledge of their latest VL result.

Little is known about the accuracy of individuals' knowledge of their own HIV biomarker status, or whether socioeconomic and other factors impact on such knowledge. In particular, there have been no studies assessing the accuracy of self‐report of VL status among people living with HIV in the UK. Despite access to free HIV care in the UK via the National Health Service, recent results from the Antiretrovirals, Sexual Transmission Risk and Attitudes (ASTRA) study indicated that socioeconomic disadvantage was associated with a substantially increased probability of virological nonsuppression and virological rebound among people on treatment for HIV infection in the UK [18](#hiv12477-bib-0018){ref-type="ref"}. In this study, we used data from ASTRA to investigate the ability of individuals on ART to correctly report their HIV VL level and CD4 count level, by comparing self‐report with the clinic‐recorded value. We also assessed the association of demographic, socioeconomic, HIV‐related and health‐related factors with inaccurate reporting of HIV VL level.

Methods {#hiv12477-sec-0006}
=======

Study design and procedures {#hiv12477-sec-0007}
---------------------------

ASTRA is a cross‐sectional questionnaire study that recruited people with diagnosed HIV infection from eight HIV out‐patient clinics in the UK between February 2011 and December 2012 [19](#hiv12477-bib-0019){ref-type="ref"}. The time period allocated for recruitment in each clinic was of sufficient duration that infrequent clinic attendees would be included in those invited to participate. Exclusion criteria were as follows: age \< 18 years; unable to understand the study questionnaire (available in English or French) because of language or cognitive difficulties; too ill or distressed to complete the questionnaire. Participants self‐completed a confidential paper questionnaire that included items on demographics (gender/sexual orientation; age; ethnicity), socioeconomic factors (UK birth/English fluency; education; employment; housing; financial hardship; supportive network assessed by a modified version of the Duke Functional Social Support questionnaire[18](#hiv12477-bib-0018){ref-type="ref"}, [20](#hiv12477-bib-0020){ref-type="ref"}), HIV‐related factors (stable partner and their HIV status; disclosure of HIV status; ART use; ART start date; ART adherence), health‐related factors (symptoms of depression and anxiety as assessed by the Patient Health Questionnaire, 9 item scale \[PHQ‐9\] [21](#hiv12477-bib-0021){ref-type="ref"} and the Generalized Anxiety Disorder 7 item scale \[GAD‐7\] [22](#hiv12477-bib-0022){ref-type="ref"}, respectively); treatment for depression.

Participants who reported that they had ever started ART were asked to report the value of their VL from the last time they received their test results, with three options: "50 copies/mL or less ('undetectable' or 'suppressed)"; "more than 50 copies/mL ('detectable' or 'raised')"; or "don\'t know". All participants were asked to report their last CD4 count result, with five options; "less than 200"; "200--350"; "351--500"; "more than 500"; or "don\'t know/can\'t remember". For all participants, the study recruiter documented, from clinic records, the latest VL and CD4 count laboratory results that were available to the participant at the time the questionnaire was issued. Therefore, information on VL and CD4 levels was available both from the participant self‐report and from the clinic record.

Agreement between self‐report and clinic record for VL and CD4 was assessed only among participants who reported currently taking ART. Accurate self‐report was defined as agreement between participant self‐report and clinic record that the latest VL was either ≤ 50 copies/mL or \> 50 copies/mL. Inaccurate self‐report was defined as either disagreement between self‐report and clinic record on the level of VL, or a response of "don\'t know" to the question on VL level. Participants who had no clinic‐recorded VL, whose clinic‐recorded VL was dated after the questionnaire issue date, or who gave no response to the question on VL level were excluded from the analysis. Similarly, accuracy of reporting CD4 count was defined as agreement between participant self‐report and clinic record that the latest CD4 count was \> 350 or ≤ 350 cells/μL. Inaccurate self‐report was defined as indicating a different CD4 count category from that of the clinic‐recorded CD4 count, or a response of "don\'t know". Analysis of factors associated with inaccurate self‐report was carried out for VL only, as it was posited that, among those on ART, VL may be monitored more regularly than CD4 count. In addition, knowledge of VL level is of particular importance in relation to decision‐making around sexual behaviour.

Statistical analysis {#hiv12477-sec-0008}
--------------------

Agreement between participant self‐report and clinic record for VL level and CD4 level was assessed among participants on ART. In order to examine the associations of demographic, socioeconomic, HIV‐related and health‐related factors with inaccurate self‐report of VL level, modified Poisson regression models with robust standard errors were used to produce unadjusted and adjusted prevalence ratios (PRs) with 95% confidence intervals (CIs) [23](#hiv12477-bib-0023){ref-type="ref"}. In multivariable analyses, each factor was considered in a separate model and adjusted only for: gender/sexual orientation \[men who have sex with men (MSM), heterosexual men and women\], age group (\< 30, 30--39, 40--49, 50--59, ≥ 60 years, and missing), ethnicity (white, black African, black other, and other/missing) and time since first starting ART group (≤ 6 months, 6 months to 1 year, 1--2 years, 2--5 years, 5--10 years, \> 10 years, and missing). Results were similar when cases with missing values for age and time since starting ART were excluded from analysis. Further adjustment for (or stratification by) clinical centre had little effect on associations; associations unadjusted for clinical centre are presented. In a separate sensitivity analysis, participants who gave no response to the question on self‐reported VL level were included in the "disagreement" category (inaccurate self‐report) rather than being excluded.

Results {#hiv12477-sec-0009}
=======

In total, 3258 patients completed a study questionnaire, of 5112 invited to participate (response rate of 64%). Of 3202 participants with ART information, 2771 (86.5%) were on ART, 366 were ART naïve, and 65 had previously taken ART but were not on ART at the time of the questionnaire. Of 2771 participants on ART, 1891 (68.2%) were MSM, 547 (19.7%) were women and 333 (12.0%) were heterosexual men (Table [1](#hiv12477-tbl-0001){ref-type="table-wrap"}). The mean age was 46.1 \[standard deviation (SD) 9.4\] years. The sample was predominantly of white ethnicity (*n* = 1894; 68.4%), with 533 (19.2%) being of black African ethnicity, 94 (3.4%) of black Caribbean or black other ethnicity, and 250 (9.0%) of other or missing ethnicity. Forty‐three per cent of participants (1155 of 2684) were not born in the UK, of whom just over a fifth (256; 22.2%) reported not being fluent in spoken English. Overall, 41.4% of participants (1115 of 2696) were educated to degree level or above and 55.9% (1509 of 2699) were in full or part‐time employment. Less than half of participants (43.8%) reported "always" having enough money for basic needs. The majority of participants (1689 of 2681; 63.0%) had started ART 5 or more years ago; 6.2% started in the past 6 months and 30.8% started between 6 months and 5 years ago. In terms of self‐reported non‐adherence: 25.0% (688 of 2756) reported having missed at least one dose of ART in the previous 2 weeks, and 17.2% (474 of 2757) reported having missed two or more consecutive days of ART on at least one occasion in the past 3 months.

###### 

Demographic, socioeconomic, HIV‐related and health‐related factors, and associations with inaccurate self‐report of clinic viral load level, among 2771 HIV‐diagnosed participants on antiretroviral therapy (ART)

                                                                                          Prevalence (*N* = 2771)[a](#hiv12477-note-0003){ref-type="fn"}   Inaccurate self‐report of clinic viral load[c](#hiv12477-note-0005){ref-type="fn"} (*n*/*N* = 434/2678)[b](#hiv12477-note-0004){ref-type="fn"}   Unadjusted PR and 95% CI[d](#hiv12477-note-0006){ref-type="fn"}   Adjusted PR and 95% CI[d](#hiv12477-note-0006){ref-type="fn"}                                                      
  --------------------------------------------------------------------------------------- ---------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------- --------------------------------------------------------------- ----- ---------- ---------------- ----- ---------- ----------------
  Gender/sexual orientation (*N* = 2771)                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  MSM[e](#hiv12477-note-0007){ref-type="fn"}                                              1891                                                             68.2                                                                                                                                             225/1852                                                          12.1                                                            1                                 1                
  Heterosexual men                                                                        333                                                              12.0                                                                                                                                             91/312                                                            29.2                                                            2.4   1.9, 3.0                    1.8   1.4, 2.4   
  Women                                                                                   547                                                              19.7                                                                                                                                             118/514                                                           23.0                                                            1.9   1.5, 2.3   \< 0.001         1.3   1.0, 1.8   \< 0.001
  Age at recruitment (*N* = 2713)                                                                                                                                                                                                                                                                                                                                                                                                                                                                
  \< 30 years[e](#hiv12477-note-0007){ref-type="fn"}                                      103                                                              3.8                                                                                                                                              29/99                                                             29.3                                                            1                                 1                
  30--39 years                                                                            569                                                              21.0                                                                                                                                             105/550                                                           19.1                                                            0.7   0.5, 0.9                    0.8   0.6, 1.1   
  40--49 years                                                                            1204                                                             44.4                                                                                                                                             170/1157                                                          14.7                                                            0.5   0.4, 0.7                    0.7   0.5, 0.9   
  50--59 years                                                                            640                                                              23.6                                                                                                                                             84/632                                                            13.3                                                            0.5   0.3, 0.7                    0.7   0.5, 1.0   
  ≥ 60 years                                                                              197                                                              7.3                                                                                                                                              31/189                                                            16.4                                                            0.6   0.4, 0.9   0.002 (*t*)      0.8   0.5, 1.2   0.16 (*t*)
  Ethnicity (*N* = 2771)                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  White[e](#hiv12477-note-0007){ref-type="fn"}                                            1894                                                             68.4                                                                                                                                             231/1854                                                          12.5                                                            1                                 1                
  Black African                                                                           533                                                              19.2                                                                                                                                             134/498                                                           26.9                                                            2.2   1.8, 2.6                    1.5   1.2, 2.0   
  Black Caribbean or black other                                                          94                                                               3.4                                                                                                                                              20/89                                                             22.5                                                            1.8   1.2, 2.7                    1.4   0.9, 2.1   
  Other/missing                                                                           250                                                              9.0                                                                                                                                              49/237                                                            20.7                                                            1.7   1.3, 2.2   \< 0.001         1.4   1.0, 1.8   0.015
  UK birth/fluency in spoken English (*N* = 2684)                                                                                                                                                                                                                                                                                                                                                                                                                                                
  Born in the UK[e](#hiv12477-note-0007){ref-type="fn"}                                   1529                                                             57.0                                                                                                                                             185/1491                                                          12.4                                                            1                                 1.0              
  Non‐UK born, fluent in spoken English                                                   899                                                              33.5                                                                                                                                             147/871                                                           16.9                                                            1.4   1.1, 1.7                    1.0   0.8, 1.3   
  Non‐UK born, speaks English quite well                                                  233                                                              8.7                                                                                                                                              70/215                                                            32.6                                                            2.6   2.1, 3.3                    1.7   1.3, 2.3   
  Non‐UK born, speaks English not at all well                                             23                                                               0.9                                                                                                                                              17/23                                                             73.9                                                            6.0   4.5, 7.9   \< 0.001 (*t*)   3.5   2.4, 5.1   \< 0.001 (*t*)
  Education (*N* = 2696)                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  University education[e](#hiv12477-note-0007){ref-type="fn"}                             1115                                                             41.4                                                                                                                                             115/1084                                                          10.6                                                            1                                 1                
  A levels/O levels or equivalent; other nonuniversity                                    1274                                                             47.3                                                                                                                                             218/1237                                                          17.6                                                            1.7   1.3, 2.1                    1.6   1.3, 2.0   
  No educational qualifications                                                           307                                                              11.4                                                                                                                                             90/291                                                            30.9                                                            2.9   2.3, 3.7   \< 0.001 (*t*)   2.7   2.1, 3.4   \< 0.001 (*t*)
  Employment status (*N* = 2699)                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  Employed (full or part‐time)[e](#hiv12477-note-0007){ref-type="fn"}                     1509                                                             55.9                                                                                                                                             182/1461                                                          12.5                                                            1                                 1                
  Unemployed                                                                              496                                                              18.4                                                                                                                                             118/477                                                           24.7                                                            2.0   1.6, 2.4                    1.7   1.4, 2.1   
  Not working because of sickness/disability                                              380                                                              14.1                                                                                                                                             63/370                                                            17.0                                                            1.4   1.1, 1.8                    1.6   1.3, 2.1   
  Retired                                                                                 180                                                              6.7                                                                                                                                              25/174                                                            14.4                                                            1.2   0.8, 1.7                    1.3   0.8, 2.0   
  Other (looking after home/family, carer, student or other)                              134                                                              5.0                                                                                                                                              32/131                                                            24.4                                                            2.0   1.4, 2.7   \< 0.001         1.4   1.0, 2.0   \< 0.001
  Housing (*N* = 2720)                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  Homeowner[e](#hiv12477-note-0007){ref-type="fn"}                                        959                                                              35.3                                                                                                                                             91/938                                                            9.7                                                             1                                 1                
  Renting (council or housing association)                                                1482                                                             54.5                                                                                                                                             255/1431                                                          17.8                                                            1.8   1.5, 2.3                    1.5   1.2, 1.9   
  Unstable/other (temporary, staying with friends or homeless)                            279                                                              10.3                                                                                                                                             79/261                                                            30.3                                                            3.1   2.4, 4.1   \< 0.001 (*t*)   2.1   1.6, 2.8   \< 0.001 (*t*)
  Money for basic needs, e.g. food and heating (*N* = 2717)                                                                                                                                                                                                                                                                                                                                                                                                                                      
  Always[e](#hiv12477-note-0007){ref-type="fn"}                                           1189                                                             43.8                                                                                                                                             121/1160                                                          10.4                                                            1                                 1                
  Mostly                                                                                  708                                                              26.1                                                                                                                                             104/692                                                           15.0                                                            1.4   1.1, 1.8                    1.4   1.1, 1.7   
  Sometimes                                                                               483                                                              17.8                                                                                                                                             103/461                                                           22.3                                                            2.1   1.7, 2.7                    1.8   1.4, 2.3   
  No                                                                                      337                                                              12.4                                                                                                                                             97/315                                                            30.8                                                            3.0   2.3, 3.7   \< 0.001 (*t*)   2.4   1.9, 3.1   \< 0.001 (*t*)
  Low supportive network (score ≤ 12; modified Duke FSSQ) (*N* = 2731)                                                                                                                                                                                                                                                                                                                                                                                                                           
  No[e](#hiv12477-note-0007){ref-type="fn"}                                               2343                                                             85.8                                                                                                                                             349/2268                                                          15.4                                                            1                                 1                
  Yes                                                                                     388                                                              14.2                                                                                                                                             75/377                                                            19.9                                                            1.3   1.0, 1.6   0.041            1.4   1.1, 1.7   0.016
  Partner status (*N* = 2752)                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  HIV‐positive stable partner[e](#hiv12477-note-0007){ref-type="fn"}                      660                                                              24.0                                                                                                                                             88/633                                                            13.9                                                            1                                 1                
  HIV‐negative or unknown status stable partner                                           905                                                              32.9                                                                                                                                             128/878                                                           14.6                                                            1.0   0.8, 1.3                    1.0   0.8, 1.3   
  No stable partner                                                                       1187                                                             43.1                                                                                                                                             216/1150                                                          18.8                                                            1.4   1.1, 1.7   0.008            1.4   1.1, 1.8   0.001
  Disclosed HIV status? (other than to health care staff) (*N* = 2754)                                                                                                                                                                                                                                                                                                                                                                                                                           
  Yes[e](#hiv12477-note-0007){ref-type="fn"}                                              2536                                                             92.1                                                                                                                                             362/2464                                                          14.7                                                            1                                 1                
  No                                                                                      218                                                              7.9                                                                                                                                              64/199                                                            32.2                                                            2.2   1.8, 2.7   \< 0.001         1.7   1.3, 2.1   \< 0.001
  Time since clinic‐recorded VL result (*N* = 2742)                                                                                                                                                                                                                                                                                                                                                                                                                                              
  ≤ 1 month[e](#hiv12477-note-0007){ref-type="fn"}                                        889                                                              32.4                                                                                                                                             125/874                                                           14.3                                                            1                                 1                
  1--6 months                                                                             1601                                                             58.4                                                                                                                                             263/1564                                                          16.8                                                            1.2   1.0, 1.4                    1.1   0.9, 1.4   
  \> 6 months                                                                             252                                                              9.2                                                                                                                                              46/240                                                            19.2                                                            1.3   1.0, 1.8   0.039 (*t*)      1.3   1.0, 1.7   0.073 (*t*)
  Time since started ART (*N* = 2681)                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  ≤ 6 months[e](#hiv12477-note-0007){ref-type="fn"}                                       166                                                              6.2                                                                                                                                              51/159                                                            32.1                                                            1                                 1                
  6 months to 1 year                                                                      104                                                              3.9                                                                                                                                              20/102                                                            19.6                                                            0.6   0.4, 1.0                    0.6   0.4, 1.0   
  1--2 years                                                                              191                                                              7.1                                                                                                                                              28/175                                                            16.0                                                            0.5   0.3, 0.8                    0.5   0.3, 0.8   
  2--5 years                                                                              531                                                              19.8                                                                                                                                             89/521                                                            17.1                                                            0.5   0.4, 0.7                    0.6   0.4, 0.7   
  5--10 years                                                                             710                                                              26.5                                                                                                                                             107/683                                                           15.7                                                            0.5   0.4, 0.6                    0.5   0.4, 0.7   
  \> 10 years                                                                             979                                                              36.5                                                                                                                                             107/958                                                           11.2                                                            0.3   0.3, 0.5   \< 0.001 (*t*)   0.4   0.3, 0.6   \< 0.001(*t*)
  ART adherence: ART doses missed in past 2 weeks (*N* = 2756)                                                                                                                                                                                                                                                                                                                                                                                                                                   
  None[e](#hiv12477-note-0007){ref-type="fn"}                                             2068                                                             75.0                                                                                                                                             293/2006                                                          14.6                                                            1                                 1                
  One                                                                                     370                                                              13.4                                                                                                                                             59/358                                                            16.5                                                            1.1   0.9, 1.5                    1.2   0.9, 1.5   
  Two                                                                                     160                                                              5.8                                                                                                                                              32/154                                                            20.8                                                            1.4   1.0, 2.0                    1.5   1.1, 2.1   
  Three or more                                                                           158                                                              5.7                                                                                                                                              46/150                                                            30.7                                                            2.1   1.6, 2.7   \< 0.001 (*t*)   2.1   1.7, 2.7   \< 0.001 (*t*)
  ART adherence: ever missed two consecutive days of ART in past 3 months? (*N* = 2757)                                                                                                                                                                                                                                                                                                                                                                                                          
  No[e](#hiv12477-note-0007){ref-type="fn"}                                               2283                                                             82.8                                                                                                                                             322/2209                                                          14.6                                                            1                                 1                
  Yes, once                                                                               155                                                              5.6                                                                                                                                              25/151                                                            16.6                                                            1.1   0.8, 1.6                    1.1   0.8, 1.6   
  Yes, two to three times                                                                 199                                                              7.2                                                                                                                                              47/193                                                            24.4                                                            1.7   1.3, 2.2                    1.5   1.2, 2.0   
  Yes, more than three times                                                              120                                                              4.4                                                                                                                                              37/114                                                            32.5                                                            2.2   1.7, 3.0   \< 0.001 (*t*)   2.2   1.6, 2.9   \< 0.001 (*t*)
  Depressive symptoms (PHQ‐9 score ≥ 10) (*N* = 2771)                                                                                                                                                                                                                                                                                                                                                                                                                                            
  No[e](#hiv12477-note-0007){ref-type="fn"}                                               2023                                                             73.0                                                                                                                                             265/1955                                                          13.6                                                            1                                 1                
  Yes                                                                                     748                                                              27.0                                                                                                                                             169/723                                                           23.4                                                            1.7   1.5, 2.1   \< 0.001         1.9   1.6, 2.2   \< 0.001
  Anxiety symptoms (GAD‐7 score ≥ 10) (*N* = 2771)                                                                                                                                                                                                                                                                                                                                                                                                                                               
  No[e](#hiv12477-note-0007){ref-type="fn"}                                               2154                                                             77.7                                                                                                                                             301/2082                                                          14.5                                                            1                                 1                
  Yes                                                                                     617                                                              22.3                                                                                                                                             133/596                                                           22.3                                                            1.5   1.3, 1.9   \< 0.001         1.6   1.3, 1.9   \< 0.001
  Treatment (medical or other) for depression (*N* = 2771)                                                                                                                                                                                                                                                                                                                                                                                                                                       
  No[e](#hiv12477-note-0007){ref-type="fn"}                                               2206                                                             79.6                                                                                                                                             334/2133                                                          15.7                                                            1                                 1                
  Yes                                                                                     565                                                              20.4                                                                                                                                             100/545                                                           18.3                                                            1.2   1.0, 1.4   0.14             1.3   1.1, 1.6   0.013

MSM, men who have sex with men; CI, confidence interval; FSSQ, Functional Social Support Questionnaire; PR, prevalence ratio; PHQ‐9, Patient Health Questionnaire, 9 item scale; GAD‐7, Generalized Anxiety Disorder 7 item scale; (*t*), test for linear trend across categories performed.

For explanatory variables with missing values for \> 30 participants, the prevalence of inaccurate self‐report among the subgroup with a missing value ranged from 16.7% (among those with missing education status) to 40.0% (among those with missing time since started ART).

Prevalence among participants on ART at the time of the questionnaire.

Disagreement between clinic‐recorded and self‐reported undetectable VL status, or "don\'t know" response for self‐report.

Analysis excludes 93 of 2771 individuals on ART. Exclusions were: missing clinic‐recorded viral load (*n* = 18); clinic‐recorded viral load dated after questionnaire issue (*n* = 11); missing self‐reported viral load (*n* = 64).

Unadjusted and adjusted prevalence ratios and 95% confidence intervals using modified Poisson regression. For adjusted analyses, each factor is included in a separate model and adjusted for "gender/sexual orientation", "age group", "ethnicity" and "time since started ART group". Denominators are equivalent for unadjusted and adjusted analyses, as in multivariable models, "age group" and "time since started ART" were fitted using a "missing" category (*n* = 51 and *n* = 80 missing values, respectively). *P* values were obtained using the score statistic.

Reference category.
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Agreement between self‐reported and clinic‐recorded VL {#hiv12477-sec-0010}
------------------------------------------------------

Among the 2771 participants on ART, the clinic‐recorded VL was not documented for 18 participants, and was dated after the questionnaire issue for a further 11 participants. In addition, 64 individuals did not provide a response to the question on self‐reported VL. Among the remaining 2678 participants, 2334 (87.2%) had clinic‐recorded VL ≤ 50 copies/mL. Self‐reported VL was as follows: 2137 (79.8%) participants reported VL ≤ 50 copies/mL, 232 (8.7%) reported VL \> 50 copies/mL, and 309 (11.5%) responded "don\'t know" (Table [2](#hiv12477-tbl-0002){ref-type="table-wrap"}a). In terms of agreement, of the 2334 participants with a clinic VL ≤ 50 copies/mL, a high proportion (88.3%; *n* = 2061) correctly self‐reported undetectable VL; 49 (2.1%) incorrectly self‐reported that their VL was detectable, while 224 (9.6%) did not know their latest VL. Of the 344 participants with clinic‐recorded VL \> 50 copies/mL, 183 (53.2%) correctly self‐reported detectable VL; however, 76 (22.1%) incorrectly self‐reported that their VL was undetectable, and 85 (24.7%) did not know their VL. Of all 2137 individuals who self‐reported an undetectable VL, the vast majority (2061; 96.4%) had clinic‐recorded VL ≤ 50 copies/mL; among the remaining 76 individuals, clinic‐recorded VL was 51--199 copies/mL for 48; 200--999 copies/mL for 13; ≥ 1000 copies/mL for 15. Therefore the prevalence of clinic‐recorded VL\<1000 copies/mL among those with self‐reported undetectable VL was 99.3% (2122/2137). Overall, agreement between an individual\'s self‐reported VL status and clinic‐recorded VL was demonstrated in 2244 (83.8%) of HIV‐positive people on ART, and disagreement (including "don\'t know") in 434 (16.2%) individuals.

###### 

\(a\) Agreement between clinic‐record and self‐report for: (a) HIV viral load level among 2678 HIV‐diagnosed participants on antiretroviral therapy (ART)[a](#hiv12477-note-0009){ref-type="fn"} and (b) CD4 count level among 2667 HIV‐diagnosed participants on ART[d](#hiv12477-note-0012){ref-type="fn"}

  \(a\)                                                                                                  
  -------------------------------------------------------------------- ------ ------ ------ ----- ------ ------
  ≤ 50 copies/mL[b](#hiv12477-note-0010){ref-type="fn"} (*N* = 2137)   2061   88.3   96.4   76    22.1   3.6
  \> 50 copies/mL[c](#hiv12477-note-0011){ref-type="fn"} (*N* = 232)   49     2.1    21.1   183   53.2   78.9
  Don\'t know (*N* = 309)                                              224    9.6    72.5   85    24.7   27.5

  -----------------------------------------------------------------------------------------------------------------------------------------------------------
  MSM (*N* = 1852)\                                                    ≤ 50 copies/mL (*N* = 1638)   \> 50 copies/mL (*N* = 214)                       
  Self‐reported latest viral load                                                                                                                      
  -------------------------------------------------------------------- ----------------------------- ----------------------------- ------ ----- ------ ------
  ≤ 50 copies/mL[b](#hiv12477-note-0010){ref-type="fn"} (*N* = 1555)   1500                          91.6                          96.5   55    25.7   3.5

  \> 50 copies/mL[c](#hiv12477-note-0011){ref-type="fn"} (*N* = 157)   30                            1.8                           19.1   127   59.3   80.9

  Don\'t know (*N* = 140)                                              108                           6.6                           77.1   32    15.0   22.9
  -----------------------------------------------------------------------------------------------------------------------------------------------------------

  --------------------------------------------------------------------------------------------------------------------------------------------------------
  Heterosexual men and women (*N* = 826)\                             ≤ 50 copies/mL (*N* = 696)   \> 50 copies/mL (*N* = 130)                      
  Self‐reported latest viral load                                                                                                                   
  ------------------------------------------------------------------- ---------------------------- ----------------------------- ------ ---- ------ ------
  ≤ 50 copies/mL[b](#hiv12477-note-0010){ref-type="fn"} (*N* = 582)   561                          80.6                          96.4   21   16.2   3.6

  \> 50 copies/mL[c](#hiv12477-note-0011){ref-type="fn"} (*N* = 75)   19                           2.7                           25.3   56   43.1   74.7

  Don\'t know (*N* = 169)                                             116                          16.7                          68.6   53   40.8   31.4
  --------------------------------------------------------------------------------------------------------------------------------------------------------

  \(b\)                                                       
  ------------------------- ----- ------ ------ ------ ------ ------
  \< 200 (*N* = 258)        132   27.3   51.2   126    5.8    49.8
  200--350 (*N* = 378)      238   49.2   63.0   140    6.4    37.0
  351--500 (*N* = 632)      56    11.6   8.9    576    26.4   91.1
  \> 500 (*N* = 1118)       9     1.9    0.8    1109   50.8   99.2
  Don\'t know (*N* = 281)   49    10.1   17.4   232    10.6   82.6

  ---------------------------------------------------------------------------------------------------------
  MSM (*N* = 1840)\                    ≤ 350 (*N* = 282)   \> 350 (*N* = 1558)                       
  Self‐reported CD4 count (cells/μL)                                                                 
  ------------------------------------ ------------------- --------------------- ------ ----- ------ ------
  \< 200 (*N* = 156)                   80                  28.4                  51.3   76    4.9    48.7

  200--350 (*N* = 257)                 155                 55.0                  60.3   102   6.5    39.7

  351--500 (*N* = 458)                 29                  10.3                  6.3    429   27.5   93.7

  \> 500 (*N* = 845)                   7                   2.5                   0.8    838   53.8   99.2

  Don\'t know (*N* = 124)              11                  3.9                   8.9    113   7.3    91.1
  ---------------------------------------------------------------------------------------------------------

                            Clinic‐recorded CD4 count (cells/μL) (latest result available to participant)                              
  ------------------------- ------------------------------------------------------------------------------- ------ ------ ----- ------ ------
  \< 200 (*N* = 102)        52                                                                              25.7   51.0   50    8.0    49.0
  200--350 (*N* = 121)      83                                                                              41.1   68.6   38    6.1    31.4
  351--500 (*N* = 174)      27                                                                              13.4   15.5   147   23.5   84.5
  \> 500 (*N* = 273)        2                                                                               1.0    0.7    271   43.4   99.3
  Don\'t know (*N* = 157)   38                                                                              18.8   24.2   119   19.0   75.8

MSM, men who have sex with men.

The analysis excludes 93 of 2771 individuals on ART. Exclusions were: missing clinic‐recorded viral load (*n* = 18); clinic‐recorded viral load dated after questionnaire issue (*n* = 11); missing self‐reported viral load (*n* = 64).

The analysis excludes 104 of 2771 individuals on ART. Exclusions were: missing clinic‐recorded CD4 count (*n* = 19); clinic‐recorded CD4 count dated after questionnaire issue (*n* = 15); missing self‐reported CD4 count (*n* = 70).

50 copies/mL or less ('undetectable' or 'suppressed').

More than 50 copies/mL ('detectable' or 'raised').

John Wiley & Sons, Ltd

Agreement between self‐reported and clinic‐recorded CD4 count {#hiv12477-sec-0011}
-------------------------------------------------------------

Among 2771 participants on ART, the clinic‐recorded CD4 count was not documented for 19 participants, and was dated after questionnaire issue for a further 15. In addition, 70 individuals did not respond to the self‐reported CD4 question. Of the remaining 2667 participants, 2183 (81.9%) had a clinic‐recorded CD4 count \> 350 cells/μL (Table [2](#hiv12477-tbl-0002){ref-type="table-wrap"}b). Of the 484 participants with a clinic CD4 count ≤ 350 cells/μL, 370 (76.4%) correctly self‐reported a CD4 count ≤ 350 cells/μL, 65 (13.4%) incorrectly self‐reported that their CD4 count was \> 350 cells/μL, and 49 (10.1%) self‐reported "don\'t know". Of 2183 participants with a CD4 count of \> 350 cells/μL, 1685 (77.2%) correctly self‐reported a CD4 count \> 350 cells/μL; 266 (12.2%) incorrectly self‐reported that their CD4 count was ≤ 350 cells/μL; 232 (10.6%) responded "don\'t know". Overall agreement between an individual\'s self‐report and the clinical record of the level of CD4 count was demonstrated in 2055 (77.1%) of HIV‐positive people on ART and disagreement (including "don\'t know") in 612 (22.9%).

Demographic and socioeconomic factors and accuracy of self‐reported VL {#hiv12477-sec-0012}
----------------------------------------------------------------------

In unadjusted analysis, demographic characteristics associated with inaccurate self‐report of VL were: gender/sexual orientation (women and heterosexual men were more likely to have inaccurate self‐report compared with MSM), younger age (those \< 30 years old were more likely to have inaccurate self‐report compared with all other age groups) and nonwhite ethnicity (Table [1](#hiv12477-tbl-0001){ref-type="table-wrap"}). There were striking associations with socioeconomic factors: non‐UK birth/low English fluency, nonuniversity education, nonemployment (other than retirement), being in rented or unstable housing, and greater financial hardship were strongly associated with a higher prevalence of inaccurate self‐report. Low supportive network was also associated with inaccurate self‐report. In analyses adjusted for gender/sexual orientation, age group, ethnicity, and time since started ART group, most associations were attenuated, but indicators of socioeconomic disadvantage remained strongly associated with inaccurate self‐report (Table [1](#hiv12477-tbl-0001){ref-type="table-wrap"}). For example, those who did not have enough money for basic needs had more than twice the prevalence of incorrectly self‐reporting their VL status compared with those who always had enough money. Similarly, compared with those who owned their own home, those in unstable accommodation had twice the prevalence of incorrectly self‐reporting their VL status. Those who were non‐UK born and reported poor English fluency had more than three times the prevalence of incorrectly self‐reporting their VL status compared with those born in the UK (which may in part reflect difficulties with comprehension of the question on the latest VL level). Gender/sexual orientation and ethnicity were independently associated with inaccurate self‐report in the model including both factors together with age group and time since started ART group, but associations were attenuated.

HIV‐related factors and accuracy of self‐reported VL {#hiv12477-sec-0013}
----------------------------------------------------

In unadjusted analyses, not having a stable partner and nondisclosure of HIV status were associated with inaccurate self‐report of VL. A shorter time since starting ART was strongly associated with inaccurate self‐report, with a particularly high prevalence among those who had very recently started ART (when VL level is likely to be changing rapidly). Self‐reported nonadherence to ART was also strongly associated with inaccurate self‐report: for example, the prevalence was twice as high among those who missed three or more doses in the past 2 weeks compared with those who reported no missed doses. The prevalence of inaccurate self‐report was also somewhat higher for those whose latest VL results were \> 6 months ago compared with more recent. These associations were similar after adjustment for gender/sexual orientation, ethnicity, age group and time since started ART group (Table [1](#hiv12477-tbl-0001){ref-type="table-wrap"}).

Mental health and accuracy of self‐reported VL {#hiv12477-sec-0014}
----------------------------------------------

Depression symptoms and anxiety symptoms were strongly associated with inaccurate self‐report in unadjusted and adjusted analyses. For example, in the adjusted analysis, the prevalence of inaccurate self‐report was increased approximately twofold for those with current depressive symptoms. Treatment for depression was also associated with inaccurate self‐report in the adjusted analysis (Table [1](#hiv12477-tbl-0001){ref-type="table-wrap"}).

Sensitivity analysis {#hiv12477-sec-0015}
--------------------

When participants who did not provide an answer to the question on self‐reported VL (*n* = 64) were included in the "disagreement" category, the proportion of participants with inaccurate self‐report of VL was 18.2% (498 of 2742). When 70 participants with missing self‐report of CD4 count level were classified as "disagreement", the proportion of participants with inaccurate self‐report of CD4 count level was 24.9% (682 of 2737). Associations of factors with inaccurate self‐report of VL were very similar to those found in the main analysis (results not shown).

Discussion {#hiv12477-sec-0016}
==========

We report on levels of agreement between self‐report and clinic‐recorded laboratory values of VL and CD4 count in people treated for HIV infection in the UK. A minority (16%) of HIV‐positive individuals on ART did not correctly self‐report whether their VL was undetectable. A quarter (25.0%) of HIV‐positive individuals on ART did not correctly self‐report their CD4 count within broad categories. Heterosexual male and female gender/sexual orientation, non‐white ethnicity, lower socioeconomic status, poor English fluency, low supportive network, not having a stable partner, nondisclosure of HIV status, having recently started ART, ART nonadherence and poorer mental health were associated with inaccurate self‐report of VL.

To our knowledge, this is the first European study to assess agreement between self‐reported and clinic‐recorded HIV VL and CD4 count. Our findings are comparable to those of several studies assessing accuracy of reporting of HIV biomarkers in people with HIV in the USA, most of which found overall moderate levels of agreement between self‐report and medical record, and which found evidence that younger age, lower education, lower health literacy and socioeconomic disadvantage were associated with inaccurate self‐report of VL and CD4 count [24](#hiv12477-bib-0024){ref-type="ref"}, [25](#hiv12477-bib-0025){ref-type="ref"}, [26](#hiv12477-bib-0026){ref-type="ref"}, [27](#hiv12477-bib-0027){ref-type="ref"}, [28](#hiv12477-bib-0028){ref-type="ref"}. Our results suggest that, even in a UK setting with free access to health care and treatment, socioeconomic disadvantage is strongly linked to lack of knowledge of HIV‐related markers.

HIV is a life‐long, chronic condition and proficient knowledge of HIV health markers among people with HIV infection supports self‐management, which can impact on engagement and retention in care [29](#hiv12477-bib-0029){ref-type="ref"}. Reasons for lack of knowledge of personal VL level in those with disadvantaged socioeconomic circumstances are likely to be complex and multifaceted. Lower levels of knowledge could in part be a consequence of health ranking as a lower priority in the context of immediate pressures. For example, financial, housing, employment or family difficulties may result in prioritization of these issues above personal health. This may impact on attendance at, or engagement with, health services. For patients who are non‐UK born with lower English fluency, this language barrier alone can result in anxiety and stress at clinic appointments, and make clinic interactions difficult and thus harder to engage with. Our study suggests that those with a lower level of education are also less likely to have accurate knowledge of their VL status, which may be linked to health literacy, and may also make HIV appointments stressful or confusing, and potentially reduce motivation to attend. Depression and other mental health problems may adversely impact on motivation and prioritization of HIV‐related health.

The results could also be interpreted as showing that health providers are less successful in actively engaging HIV‐positive people who have more complex needs in their own health care. Possible strategies to improve such engagement may include having clearer explanations after diagnosis about the importance of CD4 count and VL and what they mean for care, and having printed resources in languages other than English with involvement of peer advocates who speak the mother languages. In addition, greater training and resources on these issues for health professionals themselves may be needed. It is also important to note that lack of knowledge of personal VL level may be related to the approach taken by a doctor in discussing results with a patient. Specific values of laboratory test results may not always be given to all patients, a strategy that could be viewed as appropriate in some circumstances. In some cases, doctors may only communicate results if there is something to be concerned about. For example "undetectable viral load", or an exact value of the CD4 count, might not be directly explained by a doctor if they think their patient would prefer a more general summary of HIV health status. A doctor might choose instead perhaps to emphasize adherence and say that generally everything is okay. Insights into this level of patient−doctor communication are beyond the scope of this study.

Defining engagement in care is complex, and requires more than a single measure of appointment attendance [30](#hiv12477-bib-0030){ref-type="ref"}, [31](#hiv12477-bib-0031){ref-type="ref"}, [32](#hiv12477-bib-0032){ref-type="ref"}, [33](#hiv12477-bib-0033){ref-type="ref"}. One previous study from the USA used multiple markers including knowledge of personal CD4 count and antiretroviral treatment, medication adherence, and appointment attendance, to form a composite measure of engagement [30](#hiv12477-bib-0030){ref-type="ref"}. In our study, knowledge of personal VL level was strongly associated with ART adherence. Previous studies have found that greater engagement with care was associated with higher prevalence of viral suppression [30](#hiv12477-bib-0030){ref-type="ref"}, [33](#hiv12477-bib-0033){ref-type="ref"}. Further investigation of self‐knowledge of VL as a predictor of engagement in care could help identify those patients at risk of becoming disengaged.

Strong evidence now demonstrates that viral suppression as a result of ART substantially reduces infectiousness of HIV‐positive people to sexual partners [11](#hiv12477-bib-0011){ref-type="ref"}, [12](#hiv12477-bib-0012){ref-type="ref"}, [13](#hiv12477-bib-0013){ref-type="ref"}, [14](#hiv12477-bib-0014){ref-type="ref"}, [15](#hiv12477-bib-0015){ref-type="ref"}, [16](#hiv12477-bib-0016){ref-type="ref"}, [17](#hiv12477-bib-0017){ref-type="ref"}. Further evidence indicates that some MSM may use viral suppression in decision‐making about condomless sex [34](#hiv12477-bib-0034){ref-type="ref"}, [35](#hiv12477-bib-0035){ref-type="ref"}, [36](#hiv12477-bib-0036){ref-type="ref"}, [37](#hiv12477-bib-0037){ref-type="ref"}, [38](#hiv12477-bib-0038){ref-type="ref"}. In the ASTRA study, there was evidence that knowledge of suppressed VL impacted on condom use among MSM, although the effect was modest at the time of the study, and was not apparent for heterosexual men and women [38](#hiv12477-bib-0038){ref-type="ref"}. The accuracy of reporting an undetectable VL by HIV‐positive individuals on ART is directly relevant for their HIV‐negative sexual partners, if the HIV‐positive partner\'s VL influences decision‐making around condom use. The high level of accuracy of a self‐reported undetectable VL found in this UK study is encouraging, as this implies that decisions to have condomless sex on this basis will generally be well informed. Of all participants who self‐reported undetectable VL, \< 4% did not have a VL ≤ 50 copies/mL. Furthermore, among this subset who incorrectly reported an undetectable VL, the majority had a clinic‐recorded value \< 1000 copies/mL, making HIV transmission very unlikely. However, it is important to recognize that the prevalence of VL suppression (both overall and among those with self‐reported undetectable VL) and awareness of personal VL level may be overestimated in our study as it was conducted among HIV‐positive individuals attending clinic and who agreed to participation, suggesting a degree of engagement in care. As ART use expands and knowledge about the protective effect of ART on HIV transmission is publicized and disseminated, further attention should be paid to ensure that all HIV‐positive people on ART are able to correctly self‐report whether their latest HIV VL is undetectable. The importance of ART adherence and regular VL testing for those with HIV‐negative sexual partners should also be emphasized in this context.

A strength of the ASTRA study is that it included a large, unselected sample of people with diagnosed HIV infection in the UK, in contrast to similar studies on this topic from the USA that have mainly been conducted among low‐income or hard‐to‐reach populations and had smaller sample sizes. [24](#hiv12477-bib-0024){ref-type="ref"}, [25](#hiv12477-bib-0025){ref-type="ref"}, [26](#hiv12477-bib-0026){ref-type="ref"}, [27](#hiv12477-bib-0027){ref-type="ref"}, [28](#hiv12477-bib-0028){ref-type="ref"}. Our study has some limitations. Knowledge of HIV biomarkers may have been overestimated if such knowledge was poorer among study nonresponders, those not eligible for the study because of language difficulties, those without the opportunity to be invited because of very infrequent clinic attendance, or the small number of participants who had missing data on ART status. Although study personnel were asked to record the latest clinic values of VL and CD4 that had been communicated to the participant, accuracy of self‐report may be underestimated if cases of disagreement were attributable to participants recalling VL test results from a different date from the clinic‐recorded test.

Our results demonstrate high accuracy of a self‐report of undetectable VL among people receiving ART in the UK. Overall accuracy of self‐report varied according to demographic, socioeconomic, HIV and health‐related factors. Indicators of socioeconomic disadvantage, nondisclosure of HIV status, poorer ART adherence, and poorer mental health were strongly linked to inaccurate knowledge of VL. We identify a need for a stronger clinical focus on a specific group of patients, characterized by adverse socioeconomic circumstances, to improve their knowledge and experience of HIV care, as well as those with limited English who should be routinely offered access to interpreter services. Accurate knowledge of VL is important at both an individual and a public health level. Further consideration should be given to including it as part of a composite tool to measure engagement in care, together with a clinic plan for subsequent interventions to support people who are not engaged.

The ASTRA study presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme (RP‐PG‐0608‐10142). The views expressed in this manuscript are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The ASTRA Study Group acknowledges the support of the NIHR, through the Comprehensive Clinical Research Network. We thank all study participants for their time and effort, and gratefully acknowledge the contributions of all ASTRA clinic teams (see [Appendix](#hiv12477-app-0001){ref-type="app"}) in recruitment and data collection.
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*ASTRA clinic teams:* Royal Free Hospital: Alison Rodger, Margaret Johnson, Jeffrey McDonnell and Aderonke Adebiyi. Mortimer Market Centre: Richard Gilson, Simon Edwards, Lewis Haddow, Simon Gilson, Christina Broussard, Robert Pralat and Sonali Wayal. Brighton and Sussex University Hospital: Martin Fisher, Nicky Perry, Alex Pollard, Serge Fedele, Louise Kerr, Lisa Heald, Wendy Hadley, Kerry Hobbs, Julia Williams, Elaney Youssef, Celia Richardson and Sean Groth. North Manchester General Hospital: Ed Wilkins, Yvonne Clowes, Jennifer Cullie, Cynthia Murphy, Christina Martin, Valerie George and Andrew Thompson. Homerton University Hospital: Jane Anderson, Sifiso Mguni, Damilola Awosika and Rosalind Scourse. East Sussex Sexual Health Clinic: Kazeem Aderogba, Caron Osborne, Sue Cross, Jacqueline Whinney and Martin Jones. Newham University Hospital: Rebecca O\'Connell and Cheryl Tawana. Whipps Cross University Hospital: Monica Lascar, Zandile Maseko, Gemma Townsend, Vera Theodore and Jas Sagoo. *ASTRA core team:* Fiona Lampe, Alison Rodger, Andrew Speakman and Andrew Phillips. *ASTRA data management:* Andrew Speakman, Marina Daskalopoulou and Fiona Lampe. *ASTRA advisory group:* Lorraine Sherr, Simon Collins, Jonathan Elford, Alec Miners, Anne Johnson, Graham Hart, Anna‐Maria Geretti and Bill Burman. *CAPRA grant advisory board:* Nick Partridge, Kay Orton, Anthony Nardone and Ann Sullivan.

[^1]: See [Appendix](#hiv12477-app-0001){ref-type="app"}.
